Physicians love TCAR
Dr. Marc Schermerhon
“I think TCAR should replace most conventional transfemoral stents and likely challenge carotid endarterectomy in the future.”
Dr. Marc Schermerhon of Beth Israel Deaconess Medical Center presents data from the TCAR Surveillance Project at Vascular Live, where he compares results from Carotid Endarterectomy (CEA) and TransCarotid Artery Revascualrization (TCAR). The outcomes for Myocardial Infarction (MI), Cranial Nerve Injury (CNI), Death, Stroke, and Time spent in the hospital remained favorable to TCAR in the TCAR Surveillance Project.
Watch Dr. Schermerhon discuss the results of the TCAR Surveillance Project and give an update on the ROADSTER 2 Trial, where both sets of data presented are in favor of TCAR according to numerous aspects of the procedure.
Dr. Mazin Foteh
Cardiothoracic & Vascular Surgeons in Austin
“There’s been a significant shift in the number of CEAs versus TCAR being done.”
Dr. Mazin Foteh from Cardiothoracic & Vascular Surgeons in Austin sat down at VEITH to share his thoughts on TransCarotid Artery Revascularization (TCAR). Dr. Foteh has been involved from the very beginning and explains how the TCAR procedure and his carotid practice has evolved over the last few years.
Watch Dr. Foteh as he discusses TCAR, its benefits and the impact it will have on carotid treatments in the future.
Dr. Stoner, Dr. Melton
and Dr. Landis
“It’s a transformative technology – it’s going to transform carotid disease management.”
At VEITH, Dr. Michael Stoner of University of Rochester Medical Center, Dr. Jim Melton of Cardiovascular Health Clinic, and Dr. Gregg Landis of Northwell Health discuss how they’ve adopted TransCarotid Artery Revascularization (TCAR), what they’ve learned through this practice, and how TCAR has transformed their practice as a whole.
Watch Dr. Stoner, Dr. Melton, and Dr. Landis as they focus on how TCAR has transformed their practice and how they believe it is the evolution of future carotid treatments.
Dr. Steve Henao
“I would immediately recommend (TCAR) for my patients and my own family.”
Dr. Steve Henao focuses on the mechanics of TransCarotid Artery Revascularization (TCAR), and how flow reversal is a key aspect in the success of this treatment. Dr. Henao explains why he would consider this option for his own family as he discusses the benefits of TCAR.Take a look at how Dr. Henao highlights how TCAR works and its importance as an option for carotid treatment.
Dr. Schneider, Dr. Kokosis,
Dr. Kashyap, Dr. Cambria, Dr. Stoner
“I believe this new thing is going to change the face of carotid intervention.”
Dr. Peter Schneider of Kaiser Foundation Hospital, Honolulu, Dr. Angela Kokkosis of Stony Brook Medical, Dr. Vikram Kashyap of University Hospital, Cleveland Medical Center, Dr. Richard Cambria of Steward Health Care, and Dr. Michael Stoner of University of Rochester Medical Center all place TransCarotid Artery Revascularization (TCAR) at the forefront in the evolution of carotid treatment as a result of its benefits.
Watch the inputs of Dr. Schneider, Dr. Kokkosis, Dr. Kashyap, Dr. Cambria, and Dr. Stoner on how TCAR is a more favorable option for doctors and patients.
Dr. Michael Stoner
“TCAR has allowed us to dramatically decrease opiates from our post-op pain management protocol.”
At Vascular Live, Dr. Michael Stoner of University of Rochester Medical Center highlights the importance of endovascular procedures, including TransCarotid Artery Revascularization (TCAR), as he presents, and explains step by step, a video of a TCAR procedure being performed.
Take a look at Dr. Stoner’s talk about TCAR, and how it’s a clinically proven, less invasive procedural option.
Patients love TCAR
Hear stories from TCAR patients and learn about what they experienced in their journey to address their carotid disease.